RELATIONSHIP BETWEEN DNA DAMAGE AND CELLULAR SENESCENCE
RELATIONSHIP BETWEEN DNA DAMAGE AND CELLULAR SENESCENCE
批准号:
2757746
负责人:
LYNN HARRISON
金额:
$6.72万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2001-02-28
关键词:
DNA damage RNA Retroviridae antisense nucleic acid beta galactosidase cell cycle cell growth regulation cell senescence chimeric proteins connective tissue cells flow cytometry gene expression green fluorescent proteins histones mitochondrial DNA oxidative stress polymerase chain reaction proliferating cell nuclear antigen pyrophosphatase technology /technique development thymidine kinase transfection /expression vector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
New Investigator - Research objectives: 9. Gene expression vectors: Development and/or use of conditional gene expression vectors for the regulation of aging-and cell-specific gene expression. The goal of this project is to develop a vector which when expressed in primary human cultured cells will increase the rate of cellular senescence. Many studies have correlated oxidative DNA damage with the aging process and it has been suggested that damage specifically to mitochondrial DNA may be a key factor. However, treating cells with oxidizing agents to damage DNA results in lipid and protein oxidation. We are developing two antisense RNA expression vectors to decrease either mitochondrial or nuclear dUTPase. In the absence of this enzyme, dUTP is incorporated into the genome. Studies using bacterial dUTPase mutants indicate that the base excision repair pathway attempts to remove the dUTP resulting in DNA fragmentation and inhibition of growth. This work will therefore establish a model system in which damage is specifically produced in either the mitochondrial or nuclear genome without damaging lipids or proteins. We hypothesize that mitochondrial DNA damage will result in mitochondria dysfunction, an enhanced cellular oxidative stress and a decrease in the replicative life span of primary cells in culture. The ability of each antisense RNA to specifically decrease mitochondrial or nuclear dUTPase will be first tested by transiently expressing the RNA in transformed cells from a bi-directional promoter in combination with either a nuclear or mitochondrial dUTPase-green fluorescent protein fusion. Extracts from the cells will be used to measure the expression of the fusion. Having established the efficiency of down-regulation of dUTPase, the sequence of the antisense RNA in a retroviral vector will be converted to retrovirus and used to infect primary human cells (population doubling approximately 15). Delivery by infection will ensure the expression vectors integrate into the nuclear genome at a high frequency in the cell population. The infected population will be tested for mitochondria function and the level of fragmentation of nuclear and mitochondrial DNA. The cells will be maintained in culture and assessed for senescent-associated expression of beta-galactosidase and other senescent-related changes in gene expression, as well as alteration in growth rate and cell cycle. This study will better define the relationship between mitochondrial or nuclear DNA damage and replicative senescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hydrogen Sulfide as a Radiosensitizer for Glioblastoma
-
批准号:9813138
-
项目类别:
-
资助金额:$43.57万
-
财政年份:2019
-
负责人:LYNN HARRISON
-
依托单位:
Enhancing radiation and cisplatin HNSCC cell killing by inhibiting mitochondrial
-
批准号:8451263
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2012
-
负责人:LYNN HARRISON
-
依托单位:
Enhancing radiation and cisplatin HNSCC cell killing by inhibiting mitochondrial
-
批准号:8305841
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2012
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7909221
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6377800
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6633670
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6514437
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6755930
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6088445
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7424966
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7624393
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7260307
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7842513
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7142012
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于异质人群多源数据识别单细胞 RNA数量性状风险位点的统计学方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡铭轩
-
依托单位:
uN2CpolyG蛋白经ALYREF蛋白介导RNA转运异常在神经元核内包涵体病发病中的作用及机制研究
-
批准号:2026JJ60587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张思哲
-
依托单位:
病毒非编码RNA多样性图谱构建及其生物发生与致病机制研究
-
批准号:2026JJ60389
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:傅萍
-
依托单位:
核糖核酸酶RNase E与其抑制因子RebA通过液-液相分离调控蓝藻RNA代谢的分子机制
-
批准号:JCZRQNB202600879
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: